Mosquito-borne West Nile virus (WNV) infection is benign in most individuals but can cause encephalitis in <1% of infected individuals. We show that ∼35% of patients hospitalized for WNV disease (WNVD) in six independent cohorts from the EU and USA carry auto-Abs neutralizing IFN-α and/or -ω. The prevalence of these antibodies is highest in patients with encephalitis (∼40%), and that in individuals with silent WNV infection is as low as that in the general population. The odds ratios for WNVD in individuals with these auto-Abs relative to those without them in the general population range from 19.0 (95% CI 15.0–24.0, P value <10–15 ) for auto-Abs neutralizing only 100 pg/ml IFN-α and/or IFN-ω to 127.4 (CI 87.1–186.4, P value <10–15 ) for auto-Abs neutralizing both IFN-α and IFN-ω at a concentration of 10 ng/ml. These antibodies block the protective effect of IFN-α in Vero cells infected with WNV in vitro. Auto-Abs neutralizing IFN-α and/or IFN-ω underlie ∼40% of cases of WNV encephalitis.

Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients / A. Gervais, F. Rovida, M.A. Avanzini, S. Croce, A. Marchal, S. Lin, A. Ferrari, C. Thorball, O. Constant, T. Le Voyer, Q. Philippot, J. Rosain, M. Angelini, M. Pérez Lorenzo, L. Bizien, C. Achille, F. Trespidi, E. Burdino, I. Cassaniti, D. Lilleri, C. Fornara, J.C. Sammartino, D. Cereda, C. Marrocu, A. Piralla, C. Valsecchi, S. Ricagno, P. Cogo, O. Neth, I. Marín-Cruz, M. Pacenti, A. Sinigaglia, M. Trevisan, A. Volpe, A. Marzollo, F. Conti, T. Lazzarotto, A. Pession, P. Viale, J. Fellay, S. Ghirardello, M. Aubart, V. Ghisetti, A. Aiuti, E. Jouanguy, P. Bastard, E. Percivalle, F. Baldanti, A. Puel, M. Macdonald, C. Rice, G. Rossini, K. Murray, Y. Simonin, A. Nagy, L. Barzon, L. Abel, M. Diamond, A. Cobat, S. Zhang, J. Casanova, A. Borghesi. - In: JOURNAL OF EXPERIMENTAL MEDICINE. - ISSN 0022-1007. - 220:9(2023 Sep), pp. e20230661.1-e20230661.24. [10.1084/jem.20230661]

Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients

C. Marrocu;S. Ricagno;
2023

Abstract

Mosquito-borne West Nile virus (WNV) infection is benign in most individuals but can cause encephalitis in <1% of infected individuals. We show that ∼35% of patients hospitalized for WNV disease (WNVD) in six independent cohorts from the EU and USA carry auto-Abs neutralizing IFN-α and/or -ω. The prevalence of these antibodies is highest in patients with encephalitis (∼40%), and that in individuals with silent WNV infection is as low as that in the general population. The odds ratios for WNVD in individuals with these auto-Abs relative to those without them in the general population range from 19.0 (95% CI 15.0–24.0, P value <10–15 ) for auto-Abs neutralizing only 100 pg/ml IFN-α and/or IFN-ω to 127.4 (CI 87.1–186.4, P value <10–15 ) for auto-Abs neutralizing both IFN-α and IFN-ω at a concentration of 10 ng/ml. These antibodies block the protective effect of IFN-α in Vero cells infected with WNV in vitro. Auto-Abs neutralizing IFN-α and/or IFN-ω underlie ∼40% of cases of WNV encephalitis.
Settore MED/04 - Patologia Generale
Settore BIO/10 - Biochimica
set-2023
22-giu-2023
Article (author)
File in questo prodotto:
File Dimensione Formato  
jem_20230661.pdf

accesso aperto

Descrizione: Article
Tipologia: Publisher's version/PDF
Dimensione 5.39 MB
Formato Adobe PDF
5.39 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/990113
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact